Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study.
about
Associations between genetic variants in the ACE, AGT, AGTR1 and AGTR2 genes and renal function in the Multi-ethnic Study of AtherosclerosisDiabetic Nephropathy: New Risk Factors and Improvements in DiagnosisAngiotensin-converting enzyme gene polymophism in adult primary focal segmental glomerulosclerosis.Maternal body mass index (BMI) is independently associated with the control of diabetes mellitus in young patients.The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohortA glimpse of matrix metalloproteinases in diabetic nephropathy.Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.Inhibition of RAS in diabetic nephropathy.Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients.Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ACE and TP53.Weighted multiple testing procedures for genomic studies.Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney diseasePrognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), DiaMetabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetesMatrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathyMultiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicatGenetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetesDiabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.Celebrating 30 years of research accomplishments of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.The genetics of diabetic nephropathy.Association of genetic variants with diabetic nephropathy.The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.6. Diabetic Nephropathy[Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus].GENETICALLY INCREASED ANGIOTENSIN-I CONVERTING ENZYME ALTERS PERIPHERAL AND RENAL VASCULAR REACTIVITY TO ANGIOTENSIN II AND BRADYKININ IN MICE.
P2860
Q30433474-BE096D60-6179-4517-B847-668EC3749084Q33583018-4BC371BD-2D48-40A4-881F-53B2D6FCB328Q33688313-4146BC5F-81A5-44E9-824C-59B13FEB5300Q34284207-0723C481-4062-46E4-A403-C5D365255750Q34595620-CBA77030-1B5E-4CB4-BCEC-D7012593CCFFQ34796034-371C2676-37D5-4667-9A31-6B436CC7B2AAQ34891831-397311B8-D087-457D-8CE3-F18BFD6C61FCQ35491275-6E0CA8A9-CF77-4BA8-B848-FB78AC11D832Q35893638-90627B03-DD94-4014-A654-97B117B7DC12Q36012552-BDB0FF7C-3255-464D-8339-1023E605172EQ36200142-9C721070-0055-4F87-AE6C-5A9E7D9167F7Q36281464-EDA210CA-3E20-4E2C-BB3E-EEABD25A39A5Q36700001-352664D5-B373-4965-9DB1-ACEDC1A3E5C2Q36842087-1568CD9A-C41F-4B6F-9DEE-740B8CAA3CC5Q36842641-EA1B3FE3-CC42-4778-8019-164FC0BFFFE1Q37069135-B9E9DA66-2C4B-4B41-ACE0-4BBCC00AFF75Q37127488-47C8FA0D-9F4D-42BC-8051-54529F43D06CQ37310058-ABBE2620-C1E0-4F0E-8484-EBF0759B20CFQ37333543-C3E008CC-71CD-4C0B-96F0-3B785AA0D3D7Q37333571-DD5FFF4A-1453-4000-902A-6FC84913F3F6Q37403173-4DE0381C-6186-45EF-874F-BD0BFFDA43CEQ37403183-9F7DB8A8-ED09-4570-9949-14A1B06467EAQ37590421-8265E45B-74E0-4586-ADA2-B845F80B85C6Q38290091-EC63694A-176B-43A2-80E8-F7C3F454E46FQ38710512-FDA06352-F0DF-442C-8908-29D66B096C35Q42378585-41228DBF-4DC4-480B-800C-C2FCB65EC24BQ46625405-B409BB38-927E-455A-A95E-5AEDDD98C6F3Q47661180-D5367AC2-46AB-4C2E-8024-F4348624693F
P2860
Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Genetic variation at the ACE g ...... the DCCT/EDIC Genetics Study.
@ast
Genetic variation at the ACE g ...... the DCCT/EDIC Genetics Study.
@en
type
label
Genetic variation at the ACE g ...... the DCCT/EDIC Genetics Study.
@ast
Genetic variation at the ACE g ...... the DCCT/EDIC Genetics Study.
@en
prefLabel
Genetic variation at the ACE g ...... the DCCT/EDIC Genetics Study.
@ast
Genetic variation at the ACE g ...... the DCCT/EDIC Genetics Study.
@en
P2093
P2860
P50
P1433
P1476
Genetic variation at the ACE g ...... the DCCT/EDIC Genetics Study.
@en
P2093
Alireza Mowjoodi
Andrew P Boright
DCCT/EDIC Research Group
Lucia Mirea
Shelley B Bull
P2860
P304
P356
10.2337/DIABETES.54.4.1238
P407
P577
2005-04-01T00:00:00Z